These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clinical implications of genome-wide DNA methylation studies in acute myeloid leukemia. Li Y; Xu Q; Lv N; Wang L; Zhao H; Wang X; Guo J; Chen C; Li Y; Yu L J Hematol Oncol; 2017 Feb; 10(1):41. PubMed ID: 28153026 [TBL] [Abstract][Full Text] [Related]
5. Identification of differentially methylated markers among cytogenetic risk groups of acute myeloid leukemia. Qu X; Davison J; Du L; Storer B; Stirewalt DL; Heimfeld S; Estey E; Appelbaum FR; Fang M Epigenetics; 2015; 10(6):526-35. PubMed ID: 25996682 [TBL] [Abstract][Full Text] [Related]
6. Genomic tools in acute myeloid leukemia: From the bench to the bedside. White BS; DiPersio JF Cancer; 2014 Apr; 120(8):1134-44. PubMed ID: 24474533 [TBL] [Abstract][Full Text] [Related]
7. DNA methylation profiling in acute myeloid leukemia: from recent technological advances to biological and clinical insights. Claus R; Plass C; Armstrong SA; Bullinger L Future Oncol; 2010 Sep; 6(9):1415-31. PubMed ID: 20919827 [TBL] [Abstract][Full Text] [Related]
8. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia. Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158 [TBL] [Abstract][Full Text] [Related]
9. Close correlation of copy number aberrations detected by next-generation sequencing with results from routine cytogenetics in acute myeloid leukemia. Vosberg S; Herold T; Hartmann L; Neumann M; Opatz S; Metzeler KH; Schneider S; Graf A; Krebs S; Blum H; Baldus CD; Hiddemann W; Spiekermann K; Bohlander SK; Mansmann U; Greif PA Genes Chromosomes Cancer; 2016 Jul; 55(7):553-67. PubMed ID: 27015608 [TBL] [Abstract][Full Text] [Related]
10. Mutational profiling of acute myeloid leukemia with normal cytogenetics in Brazilian patients: the value of next-generation sequencing for genomic classification. de Noronha TR; Mitne-Neto M; Chauffaille ML J Investig Med; 2017 Dec; 65(8):1155-1158. PubMed ID: 28923882 [TBL] [Abstract][Full Text] [Related]
11. Next generation sequencing of acute myeloid leukemia: influencing prognosis. Ilyas AM; Ahmad S; Faheem M; Naseer MI; Kumosani TA; Al-Qahtani MH; Gari M; Ahmed F BMC Genomics; 2015; 16 Suppl 1(Suppl 1):S5. PubMed ID: 25924101 [TBL] [Abstract][Full Text] [Related]
12. Sequencing the AML genome, transcriptome, and epigenome. Mardis ER Semin Hematol; 2014 Oct; 51(4):250-8. PubMed ID: 25311738 [TBL] [Abstract][Full Text] [Related]
14. Genomics of AML: clinical applications of next-generation sequencing. Welch JS; Link DC Hematology Am Soc Hematol Educ Program; 2011; 2011():30-5. PubMed ID: 22160009 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Mi S; Lu J; Sun M; Li Z; Zhang H; Neilly MB; Wang Y; Qian Z; Jin J; Zhang Y; Bohlander SK; Le Beau MM; Larson RA; Golub TR; Rowley JD; Chen J Proc Natl Acad Sci U S A; 2007 Dec; 104(50):19971-6. PubMed ID: 18056805 [TBL] [Abstract][Full Text] [Related]
16. Mutational Landscape and Gene Expression Patterns in Adult Acute Myeloid Leukemias with Monosomy 7 as a Sole Abnormality. Eisfeld AK; Kohlschmidt J; Mrózek K; Volinia S; Blachly JS; Nicolet D; Oakes C; Kroll K; Orwick S; Carroll AJ; Stone RM; Byrd JC; de la Chapelle A; Bloomfield CD Cancer Res; 2017 Jan; 77(1):207-218. PubMed ID: 27784745 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic targeting and personalized approaches for AML. Roboz GJ Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):44-51. PubMed ID: 25696833 [TBL] [Abstract][Full Text] [Related]
18. A Dysregulated DNA Methylation Landscape Linked to Gene Expression in MLL-Rearranged AML. Koldobskiy MA; Abante J; Jenkinson G; Pujadas E; Tetens A; Zhao F; Tryggvadottir R; Idrizi A; Reinisch A; Majeti R; Goutsias J; Feinberg AP Epigenetics; 2020 Aug; 15(8):841-858. PubMed ID: 32114880 [TBL] [Abstract][Full Text] [Related]
19. Identification of epigenetic modifications that contribute to pathogenesis in therapy-related AML: Effective integration of genome-wide histone modification with transcriptional profiles. Yang XH; Wang B; Cunningham JM BMC Med Genomics; 2015; 8 Suppl 2(Suppl 2):S6. PubMed ID: 26043758 [TBL] [Abstract][Full Text] [Related]